Enhanced natural killer cell anti-tumor activity with nanoparticles mediated ferroptosis and potential therapeutic application in prostate cancer

Abstract Ferroptosis provides an opportunity to overcome the cancer cell therapeutic resistance and modulate the immune system. Here an interaction between ferroptosis of cancer cells and natural killer (NK) cells was investigated with a clinical grade iron oxide nanoparticle (ferumoxytol) for poten...

Full description

Bibliographic Details
Main Authors: Kwang-Soo Kim, Bongseo Choi, Hyunjun Choi, Min Jun Ko, Dong-Hwan Kim, Dong-Hyun Kim
Format: Article
Language:English
Published: BMC 2022-09-01
Series:Journal of Nanobiotechnology
Subjects:
Online Access:https://doi.org/10.1186/s12951-022-01635-y
_version_ 1811200828348825600
author Kwang-Soo Kim
Bongseo Choi
Hyunjun Choi
Min Jun Ko
Dong-Hwan Kim
Dong-Hyun Kim
author_facet Kwang-Soo Kim
Bongseo Choi
Hyunjun Choi
Min Jun Ko
Dong-Hwan Kim
Dong-Hyun Kim
author_sort Kwang-Soo Kim
collection DOAJ
description Abstract Ferroptosis provides an opportunity to overcome the cancer cell therapeutic resistance and modulate the immune system. Here an interaction between ferroptosis of cancer cells and natural killer (NK) cells was investigated with a clinical grade iron oxide nanoparticle (ferumoxytol) for potential synergistic anti-cancer effect of ferroptosis and NK cell therapy in prostate cancer. When ferumoxytol mediated ferroptosis of cancer cells was combined with NK cells, the NK cells’ cytotoxic function was increased. Observed ferroptosis mediated NK cell activation was also confirmed with IFN-γ secretion and lytic degranulation. Upregulation of ULBPs, which is one of the ligands for NK cell activating receptor NKG2D, was observed in the co-treatment of ferumoxytol mediated ferroptosis and NK cells. Additionally, HMGB1 and PD-L1 expression of cancer cells were observed in the treatment of ferroptosis + NK cells. Finally, in vivo therapeutic efficacy of ferumoxytol mediated ferroptosis and NK cell therapy was observed with significant tumor volume regression in a prostate cancer mice model. These results suggest that the NK cells’ function can be enhanced with ferumoxytol mediated ferroptosis.
first_indexed 2024-04-12T02:11:26Z
format Article
id doaj.art-8e57f2b00aed4899ab9645a8db81fd34
institution Directory Open Access Journal
issn 1477-3155
language English
last_indexed 2024-04-12T02:11:26Z
publishDate 2022-09-01
publisher BMC
record_format Article
series Journal of Nanobiotechnology
spelling doaj.art-8e57f2b00aed4899ab9645a8db81fd342022-12-22T03:52:24ZengBMCJournal of Nanobiotechnology1477-31552022-09-0120111210.1186/s12951-022-01635-yEnhanced natural killer cell anti-tumor activity with nanoparticles mediated ferroptosis and potential therapeutic application in prostate cancerKwang-Soo Kim0Bongseo Choi1Hyunjun Choi2Min Jun Ko3Dong-Hwan Kim4Dong-Hyun Kim5Department of Radiology, Feinberg School of Medicine, Northwestern UniversityDepartment of Radiology, Feinberg School of Medicine, Northwestern UniversityDepartment of Radiology, Feinberg School of Medicine, Northwestern UniversityDepartment of Radiology, Feinberg School of Medicine, Northwestern UniversitySchool of Chemical Engineering, Sungkyunkwan University (SKKU)Department of Radiology, Feinberg School of Medicine, Northwestern UniversityAbstract Ferroptosis provides an opportunity to overcome the cancer cell therapeutic resistance and modulate the immune system. Here an interaction between ferroptosis of cancer cells and natural killer (NK) cells was investigated with a clinical grade iron oxide nanoparticle (ferumoxytol) for potential synergistic anti-cancer effect of ferroptosis and NK cell therapy in prostate cancer. When ferumoxytol mediated ferroptosis of cancer cells was combined with NK cells, the NK cells’ cytotoxic function was increased. Observed ferroptosis mediated NK cell activation was also confirmed with IFN-γ secretion and lytic degranulation. Upregulation of ULBPs, which is one of the ligands for NK cell activating receptor NKG2D, was observed in the co-treatment of ferumoxytol mediated ferroptosis and NK cells. Additionally, HMGB1 and PD-L1 expression of cancer cells were observed in the treatment of ferroptosis + NK cells. Finally, in vivo therapeutic efficacy of ferumoxytol mediated ferroptosis and NK cell therapy was observed with significant tumor volume regression in a prostate cancer mice model. These results suggest that the NK cells’ function can be enhanced with ferumoxytol mediated ferroptosis.https://doi.org/10.1186/s12951-022-01635-yNK cellsFerroptosisCancer therapyNanomedicineProstate cancer
spellingShingle Kwang-Soo Kim
Bongseo Choi
Hyunjun Choi
Min Jun Ko
Dong-Hwan Kim
Dong-Hyun Kim
Enhanced natural killer cell anti-tumor activity with nanoparticles mediated ferroptosis and potential therapeutic application in prostate cancer
Journal of Nanobiotechnology
NK cells
Ferroptosis
Cancer therapy
Nanomedicine
Prostate cancer
title Enhanced natural killer cell anti-tumor activity with nanoparticles mediated ferroptosis and potential therapeutic application in prostate cancer
title_full Enhanced natural killer cell anti-tumor activity with nanoparticles mediated ferroptosis and potential therapeutic application in prostate cancer
title_fullStr Enhanced natural killer cell anti-tumor activity with nanoparticles mediated ferroptosis and potential therapeutic application in prostate cancer
title_full_unstemmed Enhanced natural killer cell anti-tumor activity with nanoparticles mediated ferroptosis and potential therapeutic application in prostate cancer
title_short Enhanced natural killer cell anti-tumor activity with nanoparticles mediated ferroptosis and potential therapeutic application in prostate cancer
title_sort enhanced natural killer cell anti tumor activity with nanoparticles mediated ferroptosis and potential therapeutic application in prostate cancer
topic NK cells
Ferroptosis
Cancer therapy
Nanomedicine
Prostate cancer
url https://doi.org/10.1186/s12951-022-01635-y
work_keys_str_mv AT kwangsookim enhancednaturalkillercellantitumoractivitywithnanoparticlesmediatedferroptosisandpotentialtherapeuticapplicationinprostatecancer
AT bongseochoi enhancednaturalkillercellantitumoractivitywithnanoparticlesmediatedferroptosisandpotentialtherapeuticapplicationinprostatecancer
AT hyunjunchoi enhancednaturalkillercellantitumoractivitywithnanoparticlesmediatedferroptosisandpotentialtherapeuticapplicationinprostatecancer
AT minjunko enhancednaturalkillercellantitumoractivitywithnanoparticlesmediatedferroptosisandpotentialtherapeuticapplicationinprostatecancer
AT donghwankim enhancednaturalkillercellantitumoractivitywithnanoparticlesmediatedferroptosisandpotentialtherapeuticapplicationinprostatecancer
AT donghyunkim enhancednaturalkillercellantitumoractivitywithnanoparticlesmediatedferroptosisandpotentialtherapeuticapplicationinprostatecancer